Export Ready — 

Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination

Bibliographic Details
Main Author: Bertoldo, Rodrigo
Publication Date: 2021
Other Authors: Peres, Gabriel Höher, Nogara, Marcelo Augusto Scheidemantel
Format: Article
Language: por
Source: Brazilian Journal of Transplantation
Download full: https://bjt.emnuvens.com.br/revista/article/view/193
Summary: Hepatocellular carcinoma (HCC) is the most prevalent liver cancer in humans. In recent decades, it has been witnessed an increasing incidence of such tumor due to the increasing amount of individuals infected with hepatitis C virus (HCV) and the increase of survival of cirrhotic patients. Some of the tools used to detect HCC are ultrasound (US), computed tomography (CT) and serum alpha-fetoprotein dosage (SAFP). Liver transplantation can be used as therapeutic measure of HCC in cirrhotic patients with tumor restricted to the liver and at an early stage. Purposes: To assess the preoperative prevalence of hepatocellular carcinoma in liver transplant recipients according to the EASL (European Association for the Study of the Liver) criteria and to associate it with the diagnostic confirmation by anatomopathological examination at the Department of Liver Transplantation at Hospital Santa Isabel in Blumenau-SC along. Methods: Clinical data were retrospectively analyzed from 71 liver transplant recipients, emphasizing the etiology of the liver transplantation indication, the serum preoperative AFP and the anatomopathological analysis of the explanted organs. Results: Preoperative prevalence of HCC was 26.76%. When considering values of the alpha-fetoprotein levels ≤ 20 ng/mL as normal, it can be found 63.16% sensitivity of such diagnostic method. In 73.68% cases, preoperative diagnosis of HCC was confirmed by anatomopathological analysis of the explanted organs. Conclusion: Both the prevalence of preoperative HCC according to the EASL criteria, such as prevalence of anatomopathological of the HCC explanted organs was higher than that reported in other studies, possibly due to the increasing cases of infection by hepatitis C occurred in recent years due to the increase in the survival of patients with cirrhosis and by the implementation since 2006 of the criterion set by the MELD score according to the Administrative Rule No. 1160 of 29 May, 2006. The prevalence of incidentalomas and the diagnosis of the serum level sensitivity for AFP were similar to those found by other authors. The HCC diagnostic confirmation occurred in 73.68% cases due to the limitation of the diagnostic tests.
id ABTO_8c89e229c51be1ea7bf8ca94e507fe3e
oai_identifier_str oai:ojs3.emnuvens.com.br:article/193
network_acronym_str ABTO
network_name_str Brazilian Journal of Transplantation
repository_id_str
spelling Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examinationPREVALÊNCIA DE DIAGNÓSTICO PRÉ-OPERATÓRIO DE CARCINOMA HEPATOCELULAR EM RECEPTORES DE TRANSPLANTE HEPÁTICO, REALIZADOS NO HOSPITAL SANTA ISABEL DE BLUMENAU-SC EM 2008, E ASSOCIAÇÃO COM A CONFIRMAÇÃO DIAGNÓSTICA POR EXAME ANATOMOPATOLÓGICOCarcinoma HepatocelularCirrose HepáticaTransplante de FígadoCarcinoma HepatocellularLiver CirrhosisLiver TransplantationHepatocellular carcinoma (HCC) is the most prevalent liver cancer in humans. In recent decades, it has been witnessed an increasing incidence of such tumor due to the increasing amount of individuals infected with hepatitis C virus (HCV) and the increase of survival of cirrhotic patients. Some of the tools used to detect HCC are ultrasound (US), computed tomography (CT) and serum alpha-fetoprotein dosage (SAFP). Liver transplantation can be used as therapeutic measure of HCC in cirrhotic patients with tumor restricted to the liver and at an early stage. Purposes: To assess the preoperative prevalence of hepatocellular carcinoma in liver transplant recipients according to the EASL (European Association for the Study of the Liver) criteria and to associate it with the diagnostic confirmation by anatomopathological examination at the Department of Liver Transplantation at Hospital Santa Isabel in Blumenau-SC along. Methods: Clinical data were retrospectively analyzed from 71 liver transplant recipients, emphasizing the etiology of the liver transplantation indication, the serum preoperative AFP and the anatomopathological analysis of the explanted organs. Results: Preoperative prevalence of HCC was 26.76%. When considering values of the alpha-fetoprotein levels ≤ 20 ng/mL as normal, it can be found 63.16% sensitivity of such diagnostic method. In 73.68% cases, preoperative diagnosis of HCC was confirmed by anatomopathological analysis of the explanted organs. Conclusion: Both the prevalence of preoperative HCC according to the EASL criteria, such as prevalence of anatomopathological of the HCC explanted organs was higher than that reported in other studies, possibly due to the increasing cases of infection by hepatitis C occurred in recent years due to the increase in the survival of patients with cirrhosis and by the implementation since 2006 of the criterion set by the MELD score according to the Administrative Rule No. 1160 of 29 May, 2006. The prevalence of incidentalomas and the diagnosis of the serum level sensitivity for AFP were similar to those found by other authors. The HCC diagnostic confirmation occurred in 73.68% cases due to the limitation of the diagnostic tests.Introdução: Carcinoma hepatocelular (CHC) é a neoplasia hepática de maior prevalência em humanos. Nas últimas décadas houve um aumento na incidência desse tumor, em consequência do número crescente de indivíduos infectados pelo vírus da hepatite C (VHC) e pelo aumento na sobrevida de pacientes cirróticos. Algumas das ferramentas utilizadas na detecção de CHC são: ultrassonografia (US), tomografia computadorizada (TC) e dosagem sérica da alfa-fetoproteína (AFP). O transplante hepático (TH) pode ser empregado como medida terapêutica de CHC em pacientes cirróticos, com tumor restrito ao fígado e em estágio precoce. Objetivos: Quantificar a prevalência pré-operatória de carcinoma hepatocelular, segundo os critérios da EASL (Associação Européia para Estudos das Doenças do Fígado) em receptores de transplante hepático e associar à confirmação diagnóstica por exame anatomopatológico, no Serviço de Transplante Hepático do Hospital Santa Isabel, de Blumenau-SC no ano de 2008. Métodos: Foram analisados retrospectivamente os dados clínicos de 71 receptores de transplante hepático, enfatizando a etiologia da indicação de TH, a dosagem sérica da AFP pré-operatória, e o diagnóstico anatomopatológico dos órgãos explantados. Resultados: A prevalência pré-operatória de CHC foi de 26,76%. Ao considerarmos valores de alfa-fetoproteína ≤ 20 ng/mL como valores normais, encontramos sensibilidade de 63,16% desse método diagnóstico. Em 73,68% dos casos, o diagnóstico pré-operatório de CHC foi confirmado pela análise anatomopatológica dos órgãos explantados. Conclusão: Tanto a prevalência pré-operatória de CHC, segundo os critérios da EASL, como a prevalência anatomopatológica de CHC dos órgãos explantados foram superiores às relatadas por outros estudos, possivelmente devido ao aumento nos casos de infecção pelo vírus da hepatite C ocorrido nos últimos anos, pelo aumento na sobrevida de pacientes com cirrose e pela implantação, desde o ano de 2006, do critério de pontuação do MELD segundo a PORTARIA Nº 1.160, DE 29 DE MAIO DE 2006. A prevalência de tumores incidentais e a sensibilidade diagnóstica do nível sérico da AFP foram similares aos encontrados por outros autores. A confirmação diagnóstica de CHC ocorreu em 73,68% dos casos, devido às limitações dos testes diagnósticos.Associação Brasileira de Transplante de Órgãos (ABTO)2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjt.emnuvens.com.br/revista/article/view/19310.53855/bjt.v14i1.193Brazilian Journal of Transplantation; Vol. 14 No. 1 (2011); 1474-1478Brazilian Journal of Transplantation; v. 14 n. 1 (2011); 1474-14782764-1589reponame:Brazilian Journal of Transplantationinstname:Associação Brasileira de Transplante de Órgãos (ABTO)instacron:ABTOporhttps://bjt.emnuvens.com.br/revista/article/view/193/180Copyright (c) 2021 Brazilian Journal of Transplantationinfo:eu-repo/semantics/openAccessBertoldo, RodrigoPeres, Gabriel HöherNogara, Marcelo Augusto Scheidemantel2021-09-28T14:28:30Zoai:ojs3.emnuvens.com.br:article/193Revistahttps://bjt.emnuvens.com.br/revistaONGhttps://bjt.emnuvens.com.br/revista/oaibjt@abto.org.brhttps://doi.org/10.53855/2764-15892764-1589opendoar:2021-09-28T14:28:30Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO)false
dc.title.none.fl_str_mv Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
PREVALÊNCIA DE DIAGNÓSTICO PRÉ-OPERATÓRIO DE CARCINOMA HEPATOCELULAR EM RECEPTORES DE TRANSPLANTE HEPÁTICO, REALIZADOS NO HOSPITAL SANTA ISABEL DE BLUMENAU-SC EM 2008, E ASSOCIAÇÃO COM A CONFIRMAÇÃO DIAGNÓSTICA POR EXAME ANATOMOPATOLÓGICO
title Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
spellingShingle Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
Bertoldo, Rodrigo
Carcinoma Hepatocelular
Cirrose Hepática
Transplante de Fígado
Carcinoma Hepatocellular
Liver Cirrhosis
Liver Transplantation
title_short Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
title_full Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
title_fullStr Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
title_full_unstemmed Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
title_sort Prevalence of preoperative diagnostic of hepatocellular carcinoma in liver transplant recipients, at Hospital Santa Isabel in Blumenau-SC in the year 2008, and association with the diagnostic confirmation by anatomopathological examination
author Bertoldo, Rodrigo
author_facet Bertoldo, Rodrigo
Peres, Gabriel Höher
Nogara, Marcelo Augusto Scheidemantel
author_role author
author2 Peres, Gabriel Höher
Nogara, Marcelo Augusto Scheidemantel
author2_role author
author
dc.contributor.author.fl_str_mv Bertoldo, Rodrigo
Peres, Gabriel Höher
Nogara, Marcelo Augusto Scheidemantel
dc.subject.por.fl_str_mv Carcinoma Hepatocelular
Cirrose Hepática
Transplante de Fígado
Carcinoma Hepatocellular
Liver Cirrhosis
Liver Transplantation
topic Carcinoma Hepatocelular
Cirrose Hepática
Transplante de Fígado
Carcinoma Hepatocellular
Liver Cirrhosis
Liver Transplantation
description Hepatocellular carcinoma (HCC) is the most prevalent liver cancer in humans. In recent decades, it has been witnessed an increasing incidence of such tumor due to the increasing amount of individuals infected with hepatitis C virus (HCV) and the increase of survival of cirrhotic patients. Some of the tools used to detect HCC are ultrasound (US), computed tomography (CT) and serum alpha-fetoprotein dosage (SAFP). Liver transplantation can be used as therapeutic measure of HCC in cirrhotic patients with tumor restricted to the liver and at an early stage. Purposes: To assess the preoperative prevalence of hepatocellular carcinoma in liver transplant recipients according to the EASL (European Association for the Study of the Liver) criteria and to associate it with the diagnostic confirmation by anatomopathological examination at the Department of Liver Transplantation at Hospital Santa Isabel in Blumenau-SC along. Methods: Clinical data were retrospectively analyzed from 71 liver transplant recipients, emphasizing the etiology of the liver transplantation indication, the serum preoperative AFP and the anatomopathological analysis of the explanted organs. Results: Preoperative prevalence of HCC was 26.76%. When considering values of the alpha-fetoprotein levels ≤ 20 ng/mL as normal, it can be found 63.16% sensitivity of such diagnostic method. In 73.68% cases, preoperative diagnosis of HCC was confirmed by anatomopathological analysis of the explanted organs. Conclusion: Both the prevalence of preoperative HCC according to the EASL criteria, such as prevalence of anatomopathological of the HCC explanted organs was higher than that reported in other studies, possibly due to the increasing cases of infection by hepatitis C occurred in recent years due to the increase in the survival of patients with cirrhosis and by the implementation since 2006 of the criterion set by the MELD score according to the Administrative Rule No. 1160 of 29 May, 2006. The prevalence of incidentalomas and the diagnosis of the serum level sensitivity for AFP were similar to those found by other authors. The HCC diagnostic confirmation occurred in 73.68% cases due to the limitation of the diagnostic tests.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://bjt.emnuvens.com.br/revista/article/view/193
10.53855/bjt.v14i1.193
url https://bjt.emnuvens.com.br/revista/article/view/193
identifier_str_mv 10.53855/bjt.v14i1.193
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://bjt.emnuvens.com.br/revista/article/view/193/180
dc.rights.driver.fl_str_mv Copyright (c) 2021 Brazilian Journal of Transplantation
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Brazilian Journal of Transplantation
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Transplante de Órgãos (ABTO)
publisher.none.fl_str_mv Associação Brasileira de Transplante de Órgãos (ABTO)
dc.source.none.fl_str_mv Brazilian Journal of Transplantation; Vol. 14 No. 1 (2011); 1474-1478
Brazilian Journal of Transplantation; v. 14 n. 1 (2011); 1474-1478
2764-1589
reponame:Brazilian Journal of Transplantation
instname:Associação Brasileira de Transplante de Órgãos (ABTO)
instacron:ABTO
instname_str Associação Brasileira de Transplante de Órgãos (ABTO)
instacron_str ABTO
institution ABTO
reponame_str Brazilian Journal of Transplantation
collection Brazilian Journal of Transplantation
repository.name.fl_str_mv Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO)
repository.mail.fl_str_mv bjt@abto.org.br
_version_ 1836111233446576128